| Miss Sarah Elizabeth Thames, MS CCC SLP | |
|
5238 Dijon Dr, Baton Rouge, LA 70808-4311 | |
| (225) 906-4097 | |
| Not Available |
| Full Name | Miss Sarah Elizabeth Thames |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 5238 Dijon Dr, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063841179 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 6608 (Louisiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Miss Sarah Elizabeth Thames, MS CCC SLP 5238 Dijon Dr, Baton Rouge, LA 70808-4311 Ph: (225) 906-4097 | Miss Sarah Elizabeth Thames, MS CCC SLP 5238 Dijon Dr, Baton Rouge, LA 70808-4311 Ph: (225) 906-4097 |
News Archive
The Pennsylvania Pediatric Medical Device Consortium has announced its latest round of seed grants to companies developing medical devices for children. The Consortium chose four companies from 11 finalists in a competition to receive seed grants of $50,000 each.
A sweeping agreement this week between the Justice Department and the state of Georgia highlights an aggressive new campaign by the Obama administration to ensure that people with mental illness and developmental disabilities can get services in their communities and not be forced to live in institutions.
Exelixis, Inc. today reported updated interim data from three ongoing trials of XL765 (SAR245409), an orally available small molecule inhibitor of phosphoinositide-3-kinase (PI3K) and mTOR. Activation of the PI3K pathway is a frequent event in human tumors, promoting cell proliferation, survival, and resistance to chemotherapy and radiotherapy.
Researchers at The Scripps Research Institute are reporting the results of a recent study that addresses why different tissues in the human body vary in their susceptibility to "amyloid" diseases, which include Alzheimer's disease and a cluster of ailments called the familial amyloidoses.
John Muir Health is offering a new cancer treatment option using the latest technology from Varian Medical Systems - The Trilogy Linear Accelerator with RapidArc Technology. The new accelerator, located at John Muir Medical Center, Concord, significantly shortens treatment sessions from 15-20 minutes to 2-5 minutes, while improving the precision of the radiotherapy.
› Verified 6 days ago
Miss Elizabeth Guillory Bailey, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12264 Queensbury Ave, Baton Rouge, LA 70815 Phone: 337-412-1344 | |
Deborah Lynne Griffin, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6021 Cottage Row Dr, Baton Rouge, LA 70817 Phone: 225-754-7663 | |
Elizabeth Tran, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 714 Jennifer Jean Dr, Baton Rouge, LA 70808 Phone: 504-914-9532 | |
Ms. Kimberly Dominick, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5536 Superior Dr Ste C, Baton Rouge, LA 70816 Phone: 225-229-4511 | |
Rebecca Woodall, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5601 Upton Dr, Baton Rouge, LA 70809 Phone: 225-293-3210 | |
Mrs. Erin Bonfanti Chesser, M.A. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6550 Sevenoaks Ave, Baton Rouge, LA 70806 Phone: 225-929-8602 | |
Barbara Germany, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18268 Petroleum Dr, Baton Rouge, LA 70809 Phone: 225-292-4138 |